Dr. Leischow's research is clinical and translational, with a focus on pharmacologic and behavioral treatments for tobacco dependence, tobacco regulatory science, and systems and network approaches to population health.

Dr Lukas's work focuses on nicotinic acetylcholine receptors, which are relevant to a number of neurological and other diseases, in addition to their roles in nicotine dependence and tobacco-related diseases.

Gewirtz uses rodent behavioral models to study the biology of emotion, with particular interest in opioid addiction, negative affect (e.g., anxiety and depression).

Tang directs Health Neuroscience Collaboratory and focuses on neuroscience of cognitive, physical & mental health and behavior change across lifespan using neuroimaging, physiological, psychosocial, genetic methods.